GE HealthCare showcases integrated cardiology care pathway solutions and new AI-driven innovations at ESC 2025

CHICAGO--(BUSINESS WIRE)--Today, leading up to the European Society of Cardiology (ESC) Congress 2025, GE HealthCare (Nasdaq: GEHC) introduced its latest suite of cardiology innovations designed to enhance clinical decision-making, improve workflow efficiency, and support earlier diagnosis and treatment of cardiovascular disease (CVD)—the world’s leading cause of death, responsible for an estimated 20.5 million deaths globally.i “Cardiovascular disease continues to place an immense and growing